Impact of respiratory protective devices on respiration: Implications for panic vulnerability during the COVID-19 pandemic.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
01 12 2020
Historique:
received: 20 07 2020
revised: 25 08 2020
accepted: 02 09 2020
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 27 10 2020
Statut: ppublish

Résumé

The wearing of respiratory protective devices (RPDs) correctly and continually in situations where people are at risk of respiratory infections is crucial for infection prevention. Certain people are poorly compliant with RPDs due to RPD-related annoyance, including respiratory discomfort. We hypothesized that individuals vulnerable to panic attacks are included in this group. No published studies on this topic are available. The evidence for our hypothesis was reviewed in this study as a starting point for future research. We selected a set of experimental studies that measured the respiratory physiological burden in RPD wearers through objective and validated methods. We conducted a bibliographic search of publications in the PubMed database (January 2000-May 2020) to identify representative studies that may be of interest for panic respiratory pathophysiology. Five studies were included. Wearing RPDs exerted significant respiratory effects, including increased breathing resistance, CO Most studies had a small sample size, with a preponderance of young participants. Different methodologies were used across the studies. Furthermore, differences in physical responses between wearing RPDs in experimental settings or daily life cannot be excluded. This research supports the idea that panic-prone individuals may be at higher risk of respiratory discomfort when wearing RPDs, thereby reducing their tolerance for these devices. Strategies to decrease discomfort should be identified to overcome the risk of poor compliance.

Sections du résumé

BACKGROUND
The wearing of respiratory protective devices (RPDs) correctly and continually in situations where people are at risk of respiratory infections is crucial for infection prevention. Certain people are poorly compliant with RPDs due to RPD-related annoyance, including respiratory discomfort. We hypothesized that individuals vulnerable to panic attacks are included in this group. No published studies on this topic are available. The evidence for our hypothesis was reviewed in this study as a starting point for future research.
METHODS
We selected a set of experimental studies that measured the respiratory physiological burden in RPD wearers through objective and validated methods. We conducted a bibliographic search of publications in the PubMed database (January 2000-May 2020) to identify representative studies that may be of interest for panic respiratory pathophysiology.
RESULTS
Five studies were included. Wearing RPDs exerted significant respiratory effects, including increased breathing resistance, CO
LIMITATIONS
Most studies had a small sample size, with a preponderance of young participants. Different methodologies were used across the studies. Furthermore, differences in physical responses between wearing RPDs in experimental settings or daily life cannot be excluded.
CONCLUSIONS
This research supports the idea that panic-prone individuals may be at higher risk of respiratory discomfort when wearing RPDs, thereby reducing their tolerance for these devices. Strategies to decrease discomfort should be identified to overcome the risk of poor compliance.

Identifiants

pubmed: 33065816
pii: S0165-0327(20)32710-5
doi: 10.1016/j.jad.2020.09.015
pmc: PMC7476564
pii:
doi:

Substances chimiques

Carbon Dioxide 142M471B3J
Oxygen S88TT14065

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-778

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

J Occup Environ Med. 2016 Sep;58(9):892-5
pubmed: 27414013
J Occup Environ Hyg. 2018 Aug;15(8):588-597
pubmed: 29750600
Psychosomatics. 2007 May-Jun;48(3):239-46
pubmed: 17478593
Respir Care. 2010 May;55(5):569-77
pubmed: 20420727
J Abnorm Psychol. 1999 Aug;108(3):473-82
pubmed: 10466271
Depress Anxiety. 2010 Apr;27(4):404-11
pubmed: 20143435
Am J Infect Control. 2010 Feb;38(1):18-25
pubmed: 20036443
Psychiatry Res. 2011 May 30;187(3):387-91
pubmed: 21477868
Ann Occup Hyg. 2011 Oct;55(8):917-21
pubmed: 21893677
J Occup Environ Hyg. 2016;13(5):372-82
pubmed: 26653154
J Affect Disord. 2013 Apr 5;146(2):158-73
pubmed: 23107756
Am J Ind Med. 1999 Apr;35(4):395-400
pubmed: 10086200
Neuropsychiatr Dis Treat. 2019 Jul 11;15:1957-1970
pubmed: 31371969
Psychol Med. 2003 Jul;33(5):879-85
pubmed: 12877402
Braz J Psychiatry. 2020 Aug;42(4):420-430
pubmed: 32074230
J Biol Eng. 2016 Feb 09;10:4
pubmed: 26865858
Int Arch Occup Environ Health. 2005 Jul;78(6):501-9
pubmed: 15918037
Arch Gen Psychiatry. 2004 Sep;61(9):913-21
pubmed: 15351770
Arch Gen Psychiatry. 1993 Apr;50(4):306-17
pubmed: 8466392
J Clin Psychiatry. 1999 Jun;60(6):379-84
pubmed: 10401916
Neurosci Biobehav Rev. 2015 Jan;48:148-59
pubmed: 25451199
Ergonomics. 2013;56(5):781-90
pubmed: 23514282
Transl Psychiatry. 2016 Sep 06;6(9):e885
pubmed: 27598969
Neurocirugia (Astur). 2008 Apr;19(2):121-6
pubmed: 18500410
Am J Respir Crit Care Med. 2005 Jun 1;171(11):1224-30
pubmed: 15764721
J Formos Med Assoc. 2004 Aug;103(8):624-8
pubmed: 15340662
Int J Methods Psychiatr Res. 2012 Sep;21(3):169-84
pubmed: 22865617
Sci Rep. 2019 Dec 12;9(1):18952
pubmed: 31831801
Compr Psychiatry. 2013 Jul;54(5):517-22
pubmed: 23332553
J Affect Disord. 2020 Apr 15;267:297-306
pubmed: 32217230
Biol Psychiatry. 1997 Dec 1;42(11):982-91
pubmed: 9386849

Auteurs

Giampaolo Perna (G)

Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Hermanas Hospitalarias, Via Roma 16, 22032 Albese con Cassano, Como, Italy. Electronic address: giampaolo.perna@hunimed.eu.

Francesco Cuniberti (F)

Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Hermanas Hospitalarias, Via Roma 16, 22032 Albese con Cassano, Como, Italy.

Silvia Daccò (S)

Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Hermanas Hospitalarias, Via Roma 16, 22032 Albese con Cassano, Como, Italy.

Maria Nobile (M)

Scientific Institute IRCCS Eugenio Medea, Bosisio Parini 23842, Lecco, Italy.

Daniela Caldirola (D)

Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20090 Pieve Emanuele, Milan, Italy; Department of Clinical Neurosciences, Villa San Benedetto Menni Hospital, Hermanas Hospitalarias, Via Roma 16, 22032 Albese con Cassano, Como, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH